Join
Live feed
·
INSIDERFilingvia Quantisnow
Adamis Pharmaceuticals Corporation logo

SEC Form 4: Marguglio David J. sold $7,117 worth of shares (11,859 units at $0.60) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 233,906 units (for withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADMP (Adamis Pharmaceuticals Corporation) and more on Quantisnow.